계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
SR One
company
About
SR One is the corporate venture capital arm of GlaxoSmithKline.
- 1 - 10
Highlights
Details
- Industries
- Financial Services,Health Care,Venture Capital
- Founded date
- Jan 1, 1985
- Number Of Employee
- 1 - 10
- Operating Status
- Active
- Investor Type
- CVC
SR One is the corporate venture capital arm of GlaxoSmithKline. The firm invests globally in emerging life science companies that are pursuing innovative science which will significantlyimpact medical care. Since 1985, SR One has invested approximately 800 million in more than 180 companies.
Investments
Number of Investments
Number of Lead Investments
7
4
SR One has made 7 investments. Their most recent investment was on
Nov 17, 2022, when Rezo Therapeutics raised $78M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Nov 17, 2022
Rezo Therapeutics
|
Series A | $78M | Biotechnology | Yes |
|
Sep 12, 2022
Nimbus Therapeutics
|
Series Unknown | $125M | Biotechnology | — |
|
Oct 3, 2019
Arcellx
|
Series B | $85M | Biopharma | — |
|
Jun 5, 2018
Nimbus Therapeutics
|
Series C | $65M | Biotechnology | Yes |
|
Mar 19, 2015
Nimbus Therapeutics
|
Series B | $43M | Biotechnology | — |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
